Detalhe da pesquisa
1.
Production of Influenza Virus Glycoproteins Using Insect Cells.
Methods Mol Biol
; 2762: 43-70, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38315359
2.
The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex.
Vaccine
; 42(14): 3365-3373, 2024 May 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38627145
3.
Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets.
Nat Commun
; 15(1): 3450, 2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38664395
4.
Enhancing the protection of influenza virus vaccines with BECC TLR4 adjuvant in aged mice.
Sci Rep
; 13(1): 715, 2023 01 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36639569
5.
Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses.
Front Bioeng Biotechnol
; 11: 1097349, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37342504
6.
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice.
Sci Adv
; 9(37): eadi4753, 2023 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37703367
7.
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses.
Nat Commun
; 13(1): 4677, 2022 08 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35945226